We are monitoring the impact of COVID-19 on Europe Companion Animal Healthcare Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1177
Share on
Share on

Europe Companion Animal Healthcare Market Research Report - Segmented By Product Type & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 1177
Pages: 132

Europe Companion Animal Healthcare Market Size & Growth (2021 to 2026):

As per the research report, the size of the Europe Companion Animal Healthcare Market is valued at USD 3.96 Billion in 2021 and estimated to reach USD 5.37 Billion by the end of 2026 with a growing potential of 6.25 %, during the forecast period 2021 to 2026.

Companies are focusing their efforts on developing new medications and vaccines for intriguing and newly diagnosed diseases, which is expected to encourage market growth. Key market players in the region are implementing market strategies such as mergers and acquisitions in the companion animal healthcare business to gain expertise in producing new active pharmaceutical ingredients/drugs.

The prevalence of zoonotic and food-borne illnesses will be a potential concern for pet animal health, resulting in increased pet/companion ownership, which will drive the European Companion Animal Healthcare Market. Pet owners' health concerns are rising, as is their demand for better nutrition.

The increasing prevalence of animal healthcare and the provision of high-quality food products have boosted the market's growth rate. Furthermore, the expansion of veterinary hospitals in both private and public entities is also boosting the market. Moreover, a rise in disposable income and current trends have increased the number of companion animals and expanded pet insurance alternatives in several regions, increasing the companion animal healthcare market demand.

Companion animal diseases are more undoubtedly to be spread to humans. For example, dog and cat bites cause a variety of illnesses in humans. Other conditions found in pets include neoplasia, distemper, parvovirus, leukemia, panleukopenia, and viral rhinotracheitis. Many of these diseases are lethal even with adequate treatment, so most pet owners have their animals vaccinated regularly. The growing need for prophylactic vaccines will propel the market forward. 

Restrictions by regulatory bodies have a negative influence on antibiotics sales, growing costs, and tightening laws on animal testing have prevented several healthcare businesses from manufacturing new advanced pharmaceuticals, among the obstacles that will hinder market expansion.

This research report on the Europe Companion Animal Healthcare Market has been segmented and sub-segmented into the following categories

By Product Type:

  • Feed Additives
  • Pharmaceuticals
  • Vaccines

By Country:

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Geographically, the companion animal healthcare market in Europe is the world's second-largest due to a rise in pet ownership government tax reduction. In addition, the market is expected to grow due to the increased implementation of regulatory standards by European regional and local governments during the overall improvement of animal healthcare. As a result, significant countries such as the United Kingdom, Germany, France, Italy, and Spain significantly contribute to the European companion animal healthcare market. Next, a biological therapeutics company producing monoclonal antibody therapy for companion animals in pain and other therapeutic areas was acquired by Zoetis in April 2017.

The UK companion animal healthcare market captured the most significant share of the companion animal healthcare market. A high level of knowledge about the health and overall wellbeing of livestock and domestic animals is the primary cause for the growth of the U.K. companion animal healthcare market. In addition, the recent events have demonstrated the United Kingdom's commitment to providing the finest possible care for animals. The United Kingdom government has invested in animal health, mainly pigs and cattle, focusing on endemic disease control and treatment. The National Office for Animal Health (NOAH) released new plans in December 2020 that urge farmers to take better care of their cattle.


Key players operating in the Europe Companion Animal Healthcare Market profiled in this report are Bayer HealthCare Pharmaceuticals LLC, Boehringer Ingelheim, Elanco, Merck & Co., Merial, Virbac, Zoetis


                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Feed Additives      

                                       Nutritional Feed Additives

                                       Medicinal Feed Additives

                                5.1.3 Pharmaceuticals   

                                5.1.4 Vaccines  

                                5.1.5 Y-o-Y Growth Analysis, By Product

                                5.1.6 Market Attractiveness Analysis, By Product               

                                5.1.7 Market Share Analysis, By Product                

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                       By Region

                                       By Product

                                6.1.4 Market Attractiveness Analysis      

                                       By Region

                                       By Product

                                6.1.5 Market Share Analysis        

                                       By Region

                                       By Product

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Pfizer Animal health Ltd                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co Inc.                        

                8.3 Sanofi Aventis Animal Health                              

                8.4 Zoetis Inc.                   

                8.5 Boehringer Ingelheim GmbH                              

                8.6 Elanco Products Company                   

                8.7 Bayer AG                     

                8.8 Novartis animal Health Inc.                  

                8.9 Virbac SA                     

                8.10 Ceva Sante Animale                             

                8.11 Vetoquinol SA                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           


                a) List of Tables                

                b) List of Figures 

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Companion Animal Healthcare Market By Product type, From 2021 to 2026 ( USD Billion )
  2. Europe Feed Additives Market By Region, From 2021 to 2026 ( USD Billion )
  3. Europe Pharmaceuticals Market By Region, From 2021 to 2026 ( USD Billion )
  4. Europe Vaccines Market By Region, From 2021 to 2026 ( USD Billion )
  5. U.K. Companion Animal Healthcare Market By Product type, From 2021 to 2026 ( USD Billion )
  6. Germany Companion Animal Healthcare Market By Product type, From 2021 to 2026 ( USD Billion )
  7. France Companion Animal Healthcare Market By Product type, From 2021 to 2026 ( USD Billion )
  8. Italy Companion Animal Healthcare Market By Product type, From 2021 to 2026 ( USD Billion )
  9. Spain Companion Animal Healthcare Market By Product type, From 2021 to 2026 ( USD Billion )
  10. Europe Companion Animal Healthcare Market By Feed addiitves, From 2021 to 2026 ( USD Billion )
  11. Europe Nutritonal Feed Additives Market By Region, From 2021 to 2026 ( USD Billion )
  12. Europe Medicinal Feed Additives Market By Region, From 2021 to 2026 ( USD Billion )
  13. U.K. Companion Animal Healthcare Market By Feed addiitves, From 2021 to 2026 ( USD Billion )
  14. Germany Companion Animal Healthcare Market By Feed addiitves, From 2021 to 2026 ( USD Billion )
  15. France Companion Animal Healthcare Market By Feed addiitves, From 2021 to 2026 ( USD Billion )
  16. Italy Companion Animal Healthcare Market By Feed addiitves, From 2021 to 2026 ( USD Billion )
  17. Spain Companion Animal Healthcare Market By Feed  addiitves, From 2021 to 2026 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample